| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $807K | — | +36.0% |
| R&D Expense | $661K | — | -24.8% |
| SG&A Expense | $648K | — | -1.4% |
| Operating Income | -$502K | — | +46.7% |
| Income Tax | $0 | — | — |
| Net Income | -$456K | — | +49.5% |
| EPS (Basic) | -$0.20 | — | +66.1% |
| EPS (Diluted) | -$0.20 | — | +66.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $7.6M | -5.7% | +38.7% |
| Total Assets | $7.9M | -5.4% | +36.6% |
| Current Liabilities | $958K | -1.0% | +43.5% |
| Total Liabilities | $958K | -1.0% | +43.5% |
| Stockholders' Equity | $7.0M | -6.0% | +35.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$536K | — | +46.5% |